Clinical trial
AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic…
NCT00427973 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00427973 |
|---|---|
| Title | AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer |
| Official title | A Phase II Study of AZD2171 in Hepatocellular Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | cediranib maleate, laboratory biomarker analysis, computed tomography, dynamic contrast-enhanced magnetic resonance imaging, pharmacological study |
| Enrollment | 17 |
| Start date | May 1, 2009 |
| Primary completion | Apr 1, 2010 |
| Completion | Mar 1, 2012 |
| First posted | Jan 29, 2007 |
| Last update posted | Oct 31, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: